In Setback for J&J’s COVID-19 Vaccine, Federal Government Pauses Distribution
The Acting FDA Commissioner told reporters that half a dozen “cases of a rare and severe type of blood clot” had occurred nationwide in women who were administered the Johnson & Johnson COVID-19 vaccine.Continue Reading